Table 3.
Demographic and clinical features of the patients with AVGs
| Variable | Ipsilateral catheter | Contralateral catheter | P value |
|---|---|---|---|
| No. of patients | 27 | 62 | |
| Age (y) | 52 ± 11 | 55 ± 15 | 0.4 |
| Male sex | 11 (41%) | 24 (39%) | 0.9 |
| Black race | 23 (85%) | 49 (79%) | 0.5 |
| Diabetes | 17 (63%) | 32 (52%) | 0.3 |
| Hypertension | 23 (85%) | 57 (90%) | 0.5 |
| CAD | 6 (22%) | 12 (19%) | 0.7 |
| PVD | 4 (15%) | 9 (14%) | 0.9 |
| CVD | 6 (22%) | 10 (16%) | 0.5 |
| CHF | 4 (15%) | 16 (26%) | 0.3 |
| AVG location | 0.8 | ||
| Forearm | 8 (30%) | 20 (32%) | |
| Upper arm | 19 (70%) | 42 (68%) | |
| AVG side | <0.001 | ||
| Left | 10 (37%) | 61 (98%) | |
| Right | 17 (63%) | 1 (2%) | |
| Catheter side | <0.001 | ||
| Left | 10 (37%) | 1 (2%) | |
| Right | 17 (63%) | 61 (98%) | |
Values for continuous variables given as mean +/− SD; values for categorical variables given as number (percentage). AVF had to have been placed after initiation of hemodialysis.
CAD, coronary artery disease; PVD, peripheral vascular disease; CVD, cerebrovascular disease, CHF, congestive heart failure; AVG, arteriovenous graft.